Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumonia

Eur Respir J. 2018 Jul 4;52(1):1800545. doi: 10.1183/13993003.00545-2018. Print 2018 Jul.

Authors

Christopher S King¹, A Whitney Brown¹, Oksana A Shlobin¹, Nargues Weir¹, Matthew Libre², Domingo Franco-Palacios³, Shahzad Ahmad⁴, Steven D Nathan¹

Affiliations

¹ Inova Fairfax Hospital Advanced Lung Disease and Lung Transplant Program, Inova Fairfax Hospital, Falls Church, VA, USA.
² Dartmouth University, Haven, NH, USA.
³ Division of Pulmonary/Critical Care, Carilion Clinic, Roanoke, VA, USA.
⁴ Center for Advanced Lung Disease, Stanford University Medical Center, Stanford, CA, USA.

PMID: 29773690
DOI: 10.1183/13993003.00545-2018

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Female
Humans
Hypertension, Pulmonary / epidemiology*
Hypertension, Pulmonary / etiology
Idiopathic Interstitial Pneumonias / complications*
Male
Middle Aged
Prevalence
Retrospective Studies
World Health Organization